TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis
出版年份 2023 全文链接
标题
TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis
作者
关键词
-
出版物
Hepatology International
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-16
DOI
10.1007/s12072-023-10591-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment
- (2022) Josep M. Llovet et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study
- (2022) Mingyue Cai et al. Frontiers in Immunology
- Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
- (2022) Zhenwei Peng et al. JOURNAL OF CLINICAL ONCOLOGY
- A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus
- (2022) Zeyu Zhang et al. Cancers
- Efficacy and safety of transarterial chemoembolization combining sorafenib with or without immune checkpoint inhibitors in previously treated patients with advanced hepatocellular carcinoma: A propensity score matching analysis
- (2022) Xue-Gang Yang et al. Frontiers in Oncology
- Lenvatinib plus transarterial chemoembolization with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A review
- (2022) Liwei Sun et al. Frontiers in Oncology
- Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study
- (2022) Peng Guo et al. Frontiers in Oncology
- Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study
- (2022) Wei-Feng Qu et al. BJS Open
- Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world
- (2022) Jin-Kai Feng et al. Frontiers in Oncology
- Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
- (2021) Liyun Zheng et al. Frontiers in Molecular Biosciences
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
- (2020) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights
- (2020) Di-Yang Xie et al. Hepatobiliary Surgery and Nutrition
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis
- (2018) Xiao-Lin Xu et al. RADIOLOGY
- Can systematic reviews with sparse data be trusted?
- (2016) A. Afshari et al. ANAESTHESIA
- Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
- (2015) Kichang Han WORLD JOURNAL OF GASTROENTEROLOGY
- Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses
- (2013) Gwang Hyeon Choi et al. RADIOLOGY
- Application of Radiotherapeutic Strategies in the BCLC-defined Stages of Hepatocellular Carcinoma
- (2012) Jihye Cha et al. Liver Cancer
- Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival
- (2011) Goh Eun Chung et al. RADIOLOGY
- Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A simulation study
- (2010) Evangelos Kontopantelis et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More